JACOBIO-B (01167.HK) +0.020 (+0.377%) Short selling $1.21M; Ratio 24.704% announced that it has recently received a USD100 million upfront collaboration payment from its strategic partner AstraZeneca PLC Ordinary Shares (AZN.US) , as well as RMB8.55 million in sales sharing paid by ALLIST (688578.SH) -1.350 (-1.442%) for the period from June to December 2025.To date, the Groups cash and bank balances, principal-protected structured deposit investments, and available banking facilities total approximately RMB2.1 billion, reflecting ample liquidity. Based on its current cash reserves and controllable expenditure plans, the Groups cash runway is expected to cover at least four years, sufficient to support the continued development of its core innovative oncology pipeline and global business expansion, further safeguarding stable business growth and the implementation of its long-term strategy.In addition, as of May 18, the Company had cumulatively repurchased 7.1478 million shares, which are held as treasury shares, for a total consideration of approximately HKD34.17 million. (jl/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.) (A Shares quote is delayed for at least 15 mins.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)
AASTOCKS Financial News